"互联网+医疗健康"背景下零售药店执业药师审方的风险防范与对策OACSTPCD

Objective To investigate the prevention measures for the risk in the process of prescription reviewed by licensed pharmacists in retail pharmacies under the background of "Internet + medical health".Methods Based on literature review and on-site research,the relevant elements of drug retail supervision by the Nanjing Administration of Market Regulation in 2021(such as errors in prescription reviewed by licensed pharmacists,sales of prescriptions by licensed pharmacists who are not on duty,etc.)were taken as examples to sort out the registration situation of licensed pharmacists,review basis,online/offline review process,the risk points of licensed pharmacists in the prescription review process of drug retail were analyzed,and the risk prevention measures and countermeasures were put forward.Results and Conclusion The risk points were concentrated in the insufficient review ability of licensed pharmacists,the contradiction between market demand and registration rate,and the lagging development of the professional technical level.In the review process,there was a lack of means for prescription compliance review,inadequate regulatory mechanisms of prescription issuance and review in internet hospitals or third-party drug purchasing platforms,and a lack of review mechanisms in cooperation with off-line medical institutions,which were easily influenced by consumer and corporate interests.It is recommended to enhance the professional ability of pharmacists,explore a diversified management model,realize a shared mechanism for prescription circulation,construct the regional center for joint prescription review,improve relevant laws and regulations,broaden resource-sharing channels for primary health care institutions,and promote the formation of a pattern of common governance through multi-party efforts to ensure the safety of medication for the public.